Literature DB >> 20585500

The regulation of synaptic function by alpha-synuclein.

Serena Bellani, Vitor L Sousa, Giuseppe Ronzitti, Flavia Valtorta, Jacopo Meldolesi, Evelina Chieregatti.   

Abstract

The cytosolic protein alpha-synuclein is enriched at the pre-synaptic terminals of almost all types of neurons in the central nervous system. alpha-Synuclein overexpression and the expression of three different mutants have been shown to sustain the pathogenesis of selected forms of Parkinson's disease. The localization of the protein and the defects found in knocked out or transgenic animals suggest a role of alpha-synuclein in the regulation of synaptic efficiency. However, the precise function of the protein and the molecular mechanisms of its action are still unclear. At synapses the synaptic vesicle release cycle is a finely tuned process composed of sequential steps that require the interconnected participation of several proteins and cytoskeletal elements. Actin microfilaments are required for the regulation of synaptic vesicle mobilization between different functional pools, for their organization at the active zone and influence the exocytotic process. We recently identified actin as a possible target of alpha-synuclein function. Through its binding to actin and the regulation of actin dynamics, alpha-synuclein could participate in the tuning of the vesicle release process, thereby modulating synaptic function and plasticity.

Entities:  

Keywords:  actin cytoskeleton; exocytosis; synaptic plasticity; synaptic vesicles; α-synuclein

Year:  2010        PMID: 20585500      PMCID: PMC2889964          DOI: 10.4161/cib.3.2.10964

Source DB:  PubMed          Journal:  Commun Integr Biol        ISSN: 1942-0889


  44 in total

Review 1.  Cell biology of the presynaptic terminal.

Authors:  Venkatesh N Murthy; Pietro De Camilli
Journal:  Annu Rev Neurosci       Date:  2003       Impact factor: 12.449

2.  Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells.

Authors:  He-Jin Lee; Seung-Jae Lee
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

Review 3.  A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders.

Authors:  Vladimir N Uversky
Journal:  J Biomol Struct Dyn       Date:  2003-10

4.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.

Authors:  A Abeliovich; Y Schmitz; I Fariñas; D Choi-Lundberg; W H Ho; P E Castillo; N Shinsky; J M Verdugo; M Armanini; A Ryan; M Hynes; H Phillips; D Sulzer; A Rosenthal
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

5.  Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein.

Authors:  Leonid Yavich; Mari Oksman; Heikki Tanila; Petri Kerokoski; Mikko Hiltunen; Thomas van Groen; Jukka Puoliväli; Pekka T Männistö; Arturo García-Horsman; Ewen MacDonald; Konrad Beyreuther; Tobias Hartmann; Pekka Jäkälä
Journal:  Neurobiol Dis       Date:  2005-11       Impact factor: 5.996

6.  Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain.

Authors:  P J Kahle; M Neumann; L Ozmen; V Muller; H Jacobsen; A Schindzielorz; M Okochi; U Leimer; H van Der Putten; A Probst; E Kremmer; H A Kretzschmar; C Haass
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

7.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration.

Authors:  Sreeganga Chandra; Gilbert Gallardo; Rafael Fernández-Chacón; Oliver M Schlüter; Thomas C Südhof
Journal:  Cell       Date:  2005-11-04       Impact factor: 41.582

8.  Conformational properties of alpha-synuclein in its free and lipid-associated states.

Authors:  D Eliezer; E Kutluay; R Bussell; G Browne
Journal:  J Mol Biol       Date:  2001-04-06       Impact factor: 5.469

9.  Identification of two distinct synucleins from human brain.

Authors:  R Jakes; M G Spillantini; M Goedert
Journal:  FEBS Lett       Date:  1994-05-23       Impact factor: 4.124

10.  Structural determinants of PLD2 inhibition by alpha-synuclein.

Authors:  Jacqueline E Payton; Richard J Perrin; Wendy S Woods; Julia M George
Journal:  J Mol Biol       Date:  2004-04-02       Impact factor: 5.469

View more
  42 in total

1.  NMR determination of pKa values in α-synuclein.

Authors:  Robyn L Croke; Sharadrao M Patil; Jason Quevreaux; Debra A Kendall; Andrei T Alexandrescu
Journal:  Protein Sci       Date:  2010-12-13       Impact factor: 6.725

2.  An α-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons.

Authors:  Christina E Khodr; Mohan K Sapru; Jyothi Pedapati; Ye Han; Neva C West; Adrian P Kells; Krystof S Bankiewicz; Martha C Bohn
Journal:  Brain Res       Date:  2011-04-22       Impact factor: 3.252

Review 3.  Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.

Authors:  Heather E Allen Reish; David G Standaert
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

Review 4.  Direct dopamine terminal regulation by local striatal microcircuitry.

Authors:  Suzanne O Nolan; Jennifer E Zachry; Amy R Johnson; Lillian J Brady; Cody A Siciliano; Erin S Calipari
Journal:  J Neurochem       Date:  2020-06-19       Impact factor: 5.372

5.  Neonatal Propofol Anesthesia Changes Expression of Synaptic Plasticity Proteins and Increases Stereotypic and Anxyolitic Behavior in Adult Rats.

Authors:  Desanka Milanovic; Vesna Pesic; Natasa Loncarevic-Vasiljkovic; Vladimir Avramovic; Vesna Tesic; Vesna Jevtovic-Todorovic; Selma Kanazir; Sabera Ruzdijic
Journal:  Neurotox Res       Date:  2017-04-24       Impact factor: 3.911

6.  Alpha-synuclein promotes early neurite outgrowth in cultured primary neurons.

Authors:  Guangwei Liu; Peng Wang; Xin Li; Yaohua Li; Shengli Xu; Kenji Uéda; Piu Chan; Shun Yu
Journal:  J Neural Transm (Vienna)       Date:  2013-02-27       Impact factor: 3.575

7.  A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.

Authors:  Hua Wang; Tessandra Stewart; Jon B Toledo; Carmen Ginghina; Lu Tang; Anzari Atik; Patrick Aro; Leslie M Shaw; John Q Trojanowski; Douglas R Galasko; Steven Edland; Poul H Jensen; Min Shi; Jing Zhang
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 8.  Membrane remodeling and mechanics: Experiments and simulations of α-Synuclein.

Authors:  Ana West; Benjamin E Brummel; Anthony R Braun; Elizabeth Rhoades; Jonathan N Sachs
Journal:  Biochim Biophys Acta       Date:  2016-03-10

9.  Overexpression of α-Synuclein Reorganises Growth Factor Profile of Human Astrocytes.

Authors:  Büşra Şengül; Erdinç Dursun; Alexei Verkhratsky; Duygu Gezen-Ak
Journal:  Mol Neurobiol       Date:  2020-09-10       Impact factor: 5.590

10.  α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment.

Authors:  Ane Korff; Changqin Liu; Carmen Ginghina; Min Shi; Jing Zhang
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.